Skip to main content
Fangzhou Inc. logo

Fangzhou Inc. — Investor Relations & Filings

Ticker · 6086 LEI · 254900EFB6KUQZPPCC72 HKEX Human health and social work activities
Open in API
Filings indexed 76 across all filing types
Latest filing 2025-12-07 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 6086

About Fangzhou Inc.

http://investors.jianke.com

Fangzhou Inc. is a leading online platform specializing in chronic disease management. The company provides comprehensive healthcare technology solutions, operating primarily through segments such as Online Retail Pharmacy Services and Comprehensive Medical Services via its Jianke Platform. Fangzhou focuses on leveraging AI to expand and enhance its chronic disease management offerings, serving a substantial user base reported to exceed 52 million registered users.

Recent filings

Filing Released Lang Actions
CHANGE OF CHAIRMAN, CHIEF EXECUTIVE OFFICER AND AUTHORISED REPRESENTATIVE&#x3b; RE-DESIGNATION OF DIRECTOR&#x3b; CHANGE IN THE COMPOSITION OF THE NOMINATION COMMITTEE
Board/Management Information Classification · 1% confidence The document is an official announcement from Fangzhou Inc. regarding the resignation of the Chairman and CEO, the re-designation of a Director, and changes to the composition of the Nomination Committee and Authorized Representatives. These are classic corporate governance and management changes, which fall directly under the 'Board/Management Information' category.
2025-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2025
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Transaction in Own Shares' (which is for specific buybacks), it is best classified as a Regulatory Filing (RNS).
2025-12-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) for share capital movements under HKEX Listing Rules (Chapter 19B), covering authorised capital, issued shares, treasury shares, and related confirmations. It is neither an annual report, earnings release, nor specific share issuance or buyback announcement, but a routine regulatory submission. It does not fit any narrowly defined category, so it falls under the general regulatory filings fallback.
2025-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2025
Regulatory Filings Classification · 1% confidence The document is a monthly return (Form FF301) filed with the Hong Kong Exchange under Listing Rule Chapter 19B, detailing month-end share capital and movement in issued/authorized shares. It is a periodic regulatory submission rather than an earnings release, management discussion, or investor presentation. It does not announce a specific capital change event or share repurchase but serves as a mandatory regulatory filing. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2025-10-08 English
2025 Interim Report
Interim / Quarterly Report Classification · 1% confidence The document is titled '2025 Interim Report' for Fangzhou Inc. It contains comprehensive financial statements, including the 'Consolidated Statement of Profit or Loss', 'Consolidated Statement of Financial Position', and 'Condensed Consolidated Statement of Cash Flow' for the six months ended June 30, 2025. It also includes management discussion and analysis, corporate governance information, and notes to the unaudited interim financial report. This aligns perfectly with the definition of an Interim/Quarterly Report (IR). H2 2025
2025-09-25 English
ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES
Regulatory Filings Classification · 1% confidence The document is an announcement made under Rule 13.10 of the Hong Kong Listing Rules regarding share price movements and confirmation of inside-information status. It is not a full financial report, earnings release, management change, dividend notice, or similar. It serves as a regulatory announcement to the Stock Exchange. Therefore it falls under the general fallback category for regulatory filings (RNS).
2025-09-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.